Literature DB >> 16488175

Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.

Amie L Phinney1, Gerda Andringa, John G J M Bol, Erik Ch Wolters, Freek L van Muiswinkel, Anne-Marie W van Dam, Benjamin Drukarch.   

Abstract

Rotenone has been reported to induce various degrees of Parkinsonism in rats. We tested whether advancing age alters the sensitivity of dopaminergic neurons to rotenone. A low, systemic dose of rotenone had no effect on young rats, but led to a 20-30% reduction of tyrosine hydroxylase-positive neurons in the substantia nigra of older rats. The effect was specific to nigral dopaminergic neurons and may be associated with the increase of glial cell activation in older rats. These data suggest that age enhances the sensitivity of dopaminergic neurons to rotenone and should be considered when assessing models of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488175     DOI: 10.1016/j.parkreldis.2005.12.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

1.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

Review 2.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

3.  The effects and mechanism of estrogen on rats with Parkinson's disease in different age groups.

Authors:  Xue-Zhong Li; Chen-Yan Sui; Qiang Chen; Yuan-Su Zhuang; Hong Zhang; Xiao-Ping Zhou
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642

5.  Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.

Authors:  Tiago Zaminelli; Raísa Wendhausen Gradowski; Taysa Bervian Bassani; Janaína Kohl Barbiero; Ronise M Santiago; Daniele Maria-Ferreira; Cristiane Hatsuko Baggio; Maria A B F Vital
Journal:  Neurotox Res       Date:  2014-04-17       Impact factor: 3.911

6.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

Authors:  S Samantaray; V H Knaryan; M K Guyton; D D Matzelle; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

7.  Rotenone-dependent changes of anterograde motor protein expression and mitochondrial mobility in brain areas related to neurodegenerative diseases.

Authors:  Thaiany Q Melo; Aline M D'unhao; Stephanie A Martins; Karen L G Farizatto; Rodrigo S Chaves; Merari F R Ferrari
Journal:  Cell Mol Neurobiol       Date:  2012-12-22       Impact factor: 5.046

8.  Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.

Authors:  Xijin Wang; Qiang Guan; Meihua Wang; Liu Yang; Jie Bai; Zhiqiang Yan; Yuhong Zhang; Zhenguo Liu
Journal:  Drug Des Devel Ther       Date:  2015-05-07       Impact factor: 4.162

9.  A phenotypic model recapitulating the neuropathology of Parkinson's disease.

Authors:  Craig F Ferris; Mathieu Marella; Brian Smerkers; Thomas M Barchet; Benjamin Gershman; Akemi Matsuno-Yagi; Takao Yagi
Journal:  Brain Behav       Date:  2013-04-17       Impact factor: 2.708

10.  Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.

Authors:  Abdelmojib Al-Wandi; Natalia Ninkina; Steven Millership; Sally J M Williamson; Paul A Jones; Vladimir L Buchman
Journal:  Neurobiol Aging       Date:  2008-12-20       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.